Abingworth as of March 31, 2019
Portfolio Holdings for Abingworth
Abingworth holds 14 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Crispr Therapeutics (CRSP) | 37.4 | $42M | 1.2M | 35.71 | |
| Sientra | 18.3 | $21M | 2.4M | 8.56 | |
| Chiasma | 9.6 | $11M | 2.1M | 5.14 | |
| Soleno Therapeutics | 8.6 | $9.6M | 4.7M | 2.06 | |
| Avedro | 7.8 | $8.7M | 719k | 12.14 | |
| Paratek Pharmaceuticals | 5.0 | $5.6M | 1.0M | 5.37 | |
| Verona Pharma Plc ads (VRNA) | 4.9 | $5.5M | 902k | 6.10 | |
| Sierra Oncology | 2.1 | $2.3M | 1.4M | 1.69 | |
| Aeglea Biotherapeutics | 1.7 | $1.9M | 241k | 8.04 | |
| Cymabay Therapeutics | 1.6 | $1.7M | 131k | 13.27 | |
| Obseva Sa | 1.0 | $1.1M | 88k | 12.70 | |
| Proteon Therapeutics | 0.9 | $1.0M | 2.0M | 0.50 | |
| Realm Therapeutics | 0.9 | $988k | 255k | 3.87 | |
| Histogenics Corp Cmn | 0.2 | $213k | 1.8M | 0.12 |
